Dysregulation of ALYREF is associated with the irregular control of the cellular division cycle and mitotic processes in HCC cells, potentially promoting HCC through the stimulation of eIF4A3 expression.92, 131. Here, ALYREF is linked to hepatocellular carcinoma.